| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 37.40B | 37.75B | 36.57B | 34.08B | 31.68B | 29.04B |
| Gross Profit | 15.45B | 15.80B | 16.96B | 34.08B | 31.68B | 14.97B |
| EBITDA | -15.52B | 11.30B | 12.01B | 14.45B | 12.35B | 9.98B |
| Net Income | 3.94B | 3.89B | 6.30B | 6.38B | 5.90B | 5.03B |
Balance Sheet | ||||||
| Total Assets | 363.80B | 360.39B | 351.48B | 346.99B | 335.88B | 299.93B |
| Cash, Cash Equivalents and Short-Term Investments | 21.30B | 34.20B | 22.07B | 19.67B | 19.63B | 15.15B |
| Total Debt | 266.30B | 265.91B | 256.62B | 251.83B | 230.81B | 206.04B |
| Total Liabilities | 304.32B | 302.91B | 293.91B | 294.55B | 282.83B | 254.66B |
| Stockholders Equity | 51.00B | 48.99B | 51.67B | 48.33B | 49.04B | 42.60B |
Cash Flow | ||||||
| Free Cash Flow | 3.10B | 1.55B | 1.17B | -11.64B | -25.33B | -31.64B |
| Operating Cash Flow | 9.15B | 9.97B | 3.73B | -7.69B | -14.87B | -24.46B |
| Investing Cash Flow | -1.92B | -3.54B | -2.40B | -1.77B | -9.85B | -10.55B |
| Financing Cash Flow | -11.99B | -5.60B | 1.59B | 9.61B | 28.52B | 42.94B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | HK$632.40M | 5.77 | 8.46% | 5.87% | -24.04% | 60.24% | |
74 Outperform | HK$21.74B | 4.01 | 13.09% | 5.67% | 3.17% | 23.13% | |
69 Neutral | HK$6.67B | 4.46 | 7.87% | 11.00% | 0.59% | -5.95% | |
68 Neutral | HK$1.39B | 3.83 | 9.89% | 7.51% | 1.11% | 3.98% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | HK$34.09B | 7.30 | 7.90% | 7.35% | -1.77% | -24.74% | |
58 Neutral | HK$324.66M | 11.16 | 1.12% | ― | -9.75% | -81.16% |
Far East Horizon Limited announced a drawdown of JPY8,000,000,000 under its Medium Term Note and Perpetual Securities Programme. The proceeds from this issuance, which is aimed at professional investors, will be used to finance and refinance green and social projects, aligning with the company’s sustainable financing framework.
The most recent analyst rating on (HK:3360) stock is a Hold with a HK$7.50 price target. To see the full list of analyst forecasts on Far East Horizon Limited stock, see the HK:3360 Stock Forecast page.
Far East Horizon Limited reported a year-on-year increase in profit attributable to ordinary shareholders for the first three quarters of 2025, driven by steady growth in its financial business. The company maintained robust asset quality and saw significant expansion in its inclusive finance segment, with interest-earning assets increasing by over 60% year-on-year. Despite a decline in revenue for Horizon Healthcare, the group remained profitable overall. The company’s effective risk management strategies ensured a stable liquidity position, and it continues to focus on its ‘finance + industry’ development strategy to enhance shareholder returns.
The most recent analyst rating on (HK:3360) stock is a Hold with a HK$7.50 price target. To see the full list of analyst forecasts on Far East Horizon Limited stock, see the HK:3360 Stock Forecast page.
Far East Horizon Limited announced an adjustment to the conversion price of its U.S.$250,000,000 zero coupon guaranteed convertible bonds due 2026, as a result of declaring an interim dividend. The conversion price adjustment, effective from 24 September 2025, will lower the price from HK$6.70 to HK$6.48 per share, increasing the maximum number of shares issuable upon full conversion. This adjustment reflects the company’s strategic financial management and could impact shareholder value and market perception.
The most recent analyst rating on (HK:3360) stock is a Hold with a HK$8.00 price target. To see the full list of analyst forecasts on Far East Horizon Limited stock, see the HK:3360 Stock Forecast page.
Far East Horizon Limited has announced the grant of share options to participants under its Share Option Scheme, involving 34,521,086 ordinary shares, which represent approximately 0.72% of the company’s total shares. This move is aimed at incentivizing participants and aligning their performance with the company’s strategic goals, potentially enhancing operational efficiency and stakeholder value.
The most recent analyst rating on (HK:3360) stock is a Buy with a HK$8.40 price target. To see the full list of analyst forecasts on Far East Horizon Limited stock, see the HK:3360 Stock Forecast page.
Far East Horizon Limited has announced an interim cash dividend of HKD 0.25 per share for the six months ending June 30, 2025. The dividend will be paid on September 24, 2025, with a record date of September 15, 2025. This announcement underscores the company’s commitment to delivering value to its shareholders and may enhance its attractiveness in the financial market.
The most recent analyst rating on (HK:3360) stock is a Buy with a HK$8.70 price target. To see the full list of analyst forecasts on Far East Horizon Limited stock, see the HK:3360 Stock Forecast page.
Far East Horizon Limited announced its unaudited interim results for the first half of 2025, showing a comparison with the same period in 2024. This announcement aligns with the regulatory requirements of the Hong Kong Stock Exchange, reflecting the company’s adherence to transparency and governance standards. The results are expected to impact the company’s operational strategies and market positioning, potentially influencing stakeholder confidence and investment decisions.
The most recent analyst rating on (HK:3360) stock is a Buy with a HK$8.40 price target. To see the full list of analyst forecasts on Far East Horizon Limited stock, see the HK:3360 Stock Forecast page.